Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4346571 | 0.78 | NPSR1 (0.34) | — | |
| SCHEMBL14417702 | 0.74 | TSHR (0.32) | TSHRTDP1 | |
| SCHEMBL26460922 | 0.74 | — | — | |
| SCHEMBL1492420 | 0.71 | TSHR (0.46) | TSHRTDP1 | |
| SCHEMBL1104143 | 0.71 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL14040249 | 0.69 | TSHR (0.32) | TSHRTDP1 | |
| SCHEMBL26460975 | 0.67 | NPSR1 (0.32) | — | |
| SCHEMBL24172013 | 0.67 | TSHR (0.37) | TSHRTDP1 | |
| SCHEMBL4591782 | 0.67 | TSHR (0.30) | TSHRTDP1 | |
| SCHEMBL7073419 | 0.67 | TSHR (0.30) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230132823-A1 | BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR | DBD THERAPEUTICS, LLC | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230132823-A1 | BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR | AR, ADRM1, PSMA3 | TSHR 3161/4885TDP1 4304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.